Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1109-1117.DOI: 10.12114/j.issn.1007-9572.2023.0483
• Original Research • Previous Articles Next Articles
Received:
2023-07-31
Revised:
2023-10-24
Published:
2024-03-20
Online:
2023-12-19
Contact:
XU Baichao
通讯作者:
徐百超
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0483
组别 | 人数 | 年龄(岁) | 身高(cm) | 体质量(kg) |
---|---|---|---|---|
对照组 | 24 | 15.0±0.8 | 153.48 ± 4.34 | 68.78 ± 1.57 |
试验组 | 20 | 14.8±0.8 | 153.40± 5.17 | 69.05 ± 1.85 |
t值 | 0.670 | 0.054 | -0.514 | |
P值 | 0.509 | 0.957 | 0.610 |
Table 1 Comparison of general characteristics of female adolescents between the control group and experimental group
组别 | 人数 | 年龄(岁) | 身高(cm) | 体质量(kg) |
---|---|---|---|---|
对照组 | 24 | 15.0±0.8 | 153.48 ± 4.34 | 68.78 ± 1.57 |
试验组 | 20 | 14.8±0.8 | 153.40± 5.17 | 69.05 ± 1.85 |
t值 | 0.670 | 0.054 | -0.514 | |
P值 | 0.509 | 0.957 | 0.610 |
组别 | 人数 | BFR(%) | WC(cm) | BMI(kg/m2) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
对照组 | 24 | 34.07±0.85 | 34.16±0.72 | -1.325 | 0.164 | 87.0±1.0 | 87.0±1.8 | -1.269 | 0.208 | 29.0±1.3 | 29.3±1.8 | -1.481 | 0.153 |
试验组 | 20 | 33.24±0.26 | 30.52±1.01 | 13.377 | <0.001 | 87.0±0.9 | 85.1±0.8 | 6.275 | <0.001 | 29.0±1.1 | 28.8±2.1 | 0.467 | 0.646 |
t值 | 2.160 | 14.904 | -1.956 | 9.462 | 0.039 | 0.056 | |||||||
P值 | 0.150 | <0.001 | 0.118 | <0.001 | 0.970 | 0.842 |
Table 2 Comparison of BFR,WC and BMI between the control group and experimental group
组别 | 人数 | BFR(%) | WC(cm) | BMI(kg/m2) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
对照组 | 24 | 34.07±0.85 | 34.16±0.72 | -1.325 | 0.164 | 87.0±1.0 | 87.0±1.8 | -1.269 | 0.208 | 29.0±1.3 | 29.3±1.8 | -1.481 | 0.153 |
试验组 | 20 | 33.24±0.26 | 30.52±1.01 | 13.377 | <0.001 | 87.0±0.9 | 85.1±0.8 | 6.275 | <0.001 | 29.0±1.1 | 28.8±2.1 | 0.467 | 0.646 |
t值 | 2.160 | 14.904 | -1.956 | 9.462 | 0.039 | 0.056 | |||||||
P值 | 0.150 | <0.001 | 0.118 | <0.001 | 0.970 | 0.842 |
组别 | 人数 | SBP | DBP | PP | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
对照组 | 24 | 132±3 | 132±3 | -1.106 | 0.312 | 82±1 | 82±1 | -1.40 | 0.890 | 50±4 | 50±3 | -1.031 | 0.142 |
试验组 | 20 | 133±3 | 127±1 | 7.651 | <0.001 | 82±1 | 81±1 | 4.053 | 0.001 | 51±3 | 46±1 | 6.795 | <0.001 |
t值 | -7.430 | 9.179 | 0.807 | 4.953 | -0.923 | 1.893 | |||||||
P值 | 0.462 | <0.001 | 0.424 | <0.001 | 0.361 | 0.065 |
Table 3 Comparison of blood pressure of female adolescents between the control group and experimental group
组别 | 人数 | SBP | DBP | PP | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
对照组 | 24 | 132±3 | 132±3 | -1.106 | 0.312 | 82±1 | 82±1 | -1.40 | 0.890 | 50±4 | 50±3 | -1.031 | 0.142 |
试验组 | 20 | 133±3 | 127±1 | 7.651 | <0.001 | 82±1 | 81±1 | 4.053 | 0.001 | 51±3 | 46±1 | 6.795 | <0.001 |
t值 | -7.430 | 9.179 | 0.807 | 4.953 | -0.923 | 1.893 | |||||||
P值 | 0.462 | <0.001 | 0.424 | <0.001 | 0.361 | 0.065 |
组别 | 人数 | FPG(μU/mL) | 胰岛素(mg/dL) | HOMA-IR | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
对照组 | 24 | 89.07±2.87 | 88.87±6.29 | 0.282 | 0.781 | 14.79±1.31 | 14.58±1.08 | 1.351 | 0.190 | 3.25±0.31 | 3.20±0.33 | 1.181 | 0.250 |
试验组 | 20 | 90.24±0.79 | 87.58±1.27 | 8.367 | <0.001 | 13.54±0.84 | 9.82±0.89 | 12.898 | <0.001 | 3.02±0.19 | 2.12±0.20 | 14.271 | <0.001 |
t值 | -1.758 | 9.326 | 2.166 | 15.641 | 0.896 | 12.828 | |||||||
P值 | 0.086 | <0.001 | 0.160 | <0.001 | 0.372 | <0.001 |
Table 4 Comparison of FPG,insulin and HOMA-IR of female adolescents between the control group and experimental group
组别 | 人数 | FPG(μU/mL) | 胰岛素(mg/dL) | HOMA-IR | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
对照组 | 24 | 89.07±2.87 | 88.87±6.29 | 0.282 | 0.781 | 14.79±1.31 | 14.58±1.08 | 1.351 | 0.190 | 3.25±0.31 | 3.20±0.33 | 1.181 | 0.250 |
试验组 | 20 | 90.24±0.79 | 87.58±1.27 | 8.367 | <0.001 | 13.54±0.84 | 9.82±0.89 | 12.898 | <0.001 | 3.02±0.19 | 2.12±0.20 | 14.271 | <0.001 |
t值 | -1.758 | 9.326 | 2.166 | 15.641 | 0.896 | 12.828 | |||||||
P值 | 0.086 | <0.001 | 0.160 | <0.001 | 0.372 | <0.001 |
组别 | 人数 | Laps(次) | MAS(km/h) | VO2max(mL·kg-1·min-1) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
对照组 | 24 | 25.00±0.97 | 24.67±1.08 | 1.261 | 0.231 | 9.52±0.12 | 9.55±0.14 | -1.239 | 0.228 | 37.03±1.09 | 37.14±0.77 | -0.684 | 0.501 |
试验组 | 20 | 21.90±1.16 | 28.04±0.65 | -23.915 | <0.001 | 9.56±0.69 | 9.87±0.49 | -21.430 | <0.001 | 36.88±0.67 | 39.00±0.44 | -11.832 | <0.001 |
t值 | 0.843 | -12.153 | -1.111 | -9.519 | 0.520 | -9.660 | |||||||
P值 | 0.386 | <0.001 | 0.273 | <0.001 | 0.606 | <0.001 |
Table 5 Comparison of Laps,MAS and VO2max of female adolescents between the control group and experimental group
组别 | 人数 | Laps(次) | MAS(km/h) | VO2max(mL·kg-1·min-1) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
对照组 | 24 | 25.00±0.97 | 24.67±1.08 | 1.261 | 0.231 | 9.52±0.12 | 9.55±0.14 | -1.239 | 0.228 | 37.03±1.09 | 37.14±0.77 | -0.684 | 0.501 |
试验组 | 20 | 21.90±1.16 | 28.04±0.65 | -23.915 | <0.001 | 9.56±0.69 | 9.87±0.49 | -21.430 | <0.001 | 36.88±0.67 | 39.00±0.44 | -11.832 | <0.001 |
t值 | 0.843 | -12.153 | -1.111 | -9.519 | 0.520 | -9.660 | |||||||
P值 | 0.386 | <0.001 | 0.273 | <0.001 | 0.606 | <0.001 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
张艺宏,徐峻华,何本祥. 运动机能评定理论与方法[M]. 北京:科学出版社,2018.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[1] | PENG Lei, ZHU Kexiang. Research Progress of Sarcopenic Obesity in Cancer [J]. Chinese General Practice, 2024, 27(06): 643-649. |
[2] | YANG Mukun, JIA Xiaoxiang, REN Zhenghong, GU Bei, BAI Wenpei. Menopause or Chronologic Aging? A Prospective Cohort Study on Risk Factors for Coronary Heart Disease in Middle-aged Women [J]. Chinese General Practice, 2024, 27(03): 280-285. |
[3] | LI Yaping, LI Xia. Research Progress of Correlation and Underlying Mechanisms between Metabolic Syndrome and Alzheimer's Disease [J]. Chinese General Practice, 2024, 27(03): 268-272. |
[4] | ZHOU Jing, JIA Jianguo, LIN Yixin, WU Shuang, DAI Shilong, WANG Mingjun, ZHANG Qingsong. Association of Different Metabolic Obesity Phenotypes with Breast Cancer Risk in Women: a Prospective Cohort Study [J]. Chinese General Practice, 2024, 27(02): 150-155. |
[5] | LENG Zheng qing, ALIMUJIANG· yimiti·taerkin. Growth Trends and Overweight/Obesity Status of Children Aged 7-12 Years in China from 2014 to 2020 [J]. Chinese General Practice, 2024, 27(01): 36-44. |
[6] | LI Jixin, QIU Linjie, REN Yan, WANG Wenru, LI Meijie, ZHANG Jin. The Correlation of Dietary Inflammatory Index with Overweight, Obesity and Abdominal Obesity: a Meta-analysis [J]. Chinese General Practice, 2023, 26(32): 4089-4097. |
[7] | PAN Yaojia, WANG Weiqiang, YI Weizhuo, GAO Bing, FU Fanglin, HAN Zheng, SUN Meng, DONG Yaqin, GU Huaicong. Relationship between Triglyceride-glucose Index and Risk of Cardiovascular Diseases in Middle-aged Obese Residents of Different Genders [J]. Chinese General Practice, 2023, 26(29): 3628-3635. |
[8] | WANG Qianqian, WANG Xiaohang, ZHOU Xiaoying, QIU Shanhu, SUN Zilin. Exercise is the Foundation of Weight Loss [J]. Chinese General Practice, 2023, 26(28): 3471-3476. |
[9] | JIANG Qiuhui, LI Xuejun. Exercise is Not the Foundation of Weight Loss [J]. Chinese General Practice, 2023, 26(28): 3477-3481. |
[10] | ZHANG Li, ZHENG Wei, WANG Jia, YUAN Xianxian, HAN Weiling, HUANG Junhua, TIAN Zhihong, LI Guanghui. Comparison of Gestational Weight Gain and Pregnancy Outcomes in Chinese Women with Singleton Pregnancy Using Standard of Recommendation for Weight Gain during Pregnancy Period and Guidelines by the Institute of Medicine [J]. Chinese General Practice, 2023, 26(24): 2959-2967. |
[11] | YIN Cong, DIAO He, SHENG Wei, CAO Yan, BAI Wenpei. Influence of Daily Self-weighing Supported by Online Supervision on Body Composition and Emotions in Overweight/Obese Women with Anxiety and Depression [J]. Chinese General Practice, 2023, 26(24): 2992-2996. |
[12] | ZHANG Lina, WANG Yan, ZHANG Kanghuai, LI Youjia. Clinical Research Progress of Tirzepatide: a New Hypoglycemic Agent [J]. Chinese General Practice, 2023, 26(15): 1902-1908. |
[13] | WANG Junwei, LIN Lingjun, SONG Linling, CHENG Xiaocui, NIE Xiuling. Association between Serum Potassium and Metabolic-associated Fatty Liver Disease in Patients with Primary Gout [J]. Chinese General Practice, 2023, 26(12): 1479-1484. |
[14] | CAI Ming, WANG Liyan, YANG Ruoyu, LIANG Leichao, YANG Yuanyuan, JIA Shihao, CHEN Ruiyi, REN Yu, LIU Qianle, HU Jingyun. Short-term High-intensity Interval Training Reduces the Accumulation of Advanced Glycation End Products and the Risk of Cardiovascular Disease in Normal Weight Obese Female University Students: a Randomized Controlled Trial [J]. Chinese General Practice, 2023, 26(12): 1472-1478. |
[15] | LIU Yanhui, CHEN Shuchun. Interpretation and Clinical Significance of the Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement [J]. Chinese General Practice, 2023, 26(12): 1422-1428. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||